Ananda Ghosh
Stock Analyst at HC Wainwright & Co.
(2.64)
# 1,152
Out of 5,182 analysts
22
Total ratings
34.78%
Success rate
2.31%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ananda Ghosh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MAZE Maze Therapeutics | Maintains: Buy | $60 → $110 | $28.13 | +291.04% | 5 | Mar 25, 2026 | |
| GPCR Structure Therapeutics | Maintains: Buy | $114 → $100 | $52.01 | +92.27% | 4 | Mar 16, 2026 | |
| DYN Dyne Therapeutics | Maintains: Buy | $60 → $50 | $20.28 | +146.55% | 3 | Mar 3, 2026 | |
| ACAD ACADIA Pharmaceuticals | Reiterates: Buy | $37 | $22.01 | +68.11% | 2 | Feb 3, 2026 | |
| STOK Stoke Therapeutics | Maintains: Buy | $35 → $50 | $36.40 | +37.38% | 1 | Dec 15, 2025 | |
| PEPG PepGen | Maintains: Buy | $18 → $20 | $1.76 | +1,036.36% | 3 | Nov 13, 2025 | |
| IVA Inventiva | Maintains: Buy | $20 → $24 | $5.76 | +316.67% | 2 | Oct 9, 2025 | |
| SKYE Skye Bioscience | Initiates: Buy | $20 | $0.76 | +2,531.58% | 1 | Sep 30, 2025 | |
| ANNX Annexon | Reiterates: Buy | $14 | $6.49 | +115.72% | 1 | Aug 15, 2025 |
Maze Therapeutics
Mar 25, 2026
Maintains: Buy
Price Target: $60 → $110
Current: $28.13
Upside: +291.04%
Structure Therapeutics
Mar 16, 2026
Maintains: Buy
Price Target: $114 → $100
Current: $52.01
Upside: +92.27%
Dyne Therapeutics
Mar 3, 2026
Maintains: Buy
Price Target: $60 → $50
Current: $20.28
Upside: +146.55%
ACADIA Pharmaceuticals
Feb 3, 2026
Reiterates: Buy
Price Target: $37
Current: $22.01
Upside: +68.11%
Stoke Therapeutics
Dec 15, 2025
Maintains: Buy
Price Target: $35 → $50
Current: $36.40
Upside: +37.38%
PepGen
Nov 13, 2025
Maintains: Buy
Price Target: $18 → $20
Current: $1.76
Upside: +1,036.36%
Inventiva
Oct 9, 2025
Maintains: Buy
Price Target: $20 → $24
Current: $5.76
Upside: +316.67%
Skye Bioscience
Sep 30, 2025
Initiates: Buy
Price Target: $20
Current: $0.76
Upside: +2,531.58%
Annexon
Aug 15, 2025
Reiterates: Buy
Price Target: $14
Current: $6.49
Upside: +115.72%